摘要
理论依据:研究已经暗示JAK2 / STAT3信号与急性胰腺炎(AP)的发病和严重程度呈正相关。然而,JAK2 / STAT3信号在体内急性胰腺炎发病机制中的确切功能研究缺失,其潜在的治疗靶点和潜在的机制尚待确定。 目的:本研究旨在探讨JAK2 / STAT3信号通路在高脂血症加强型CA的发病机制中的作用及其作为治疗靶点的可能性。 方法和结果:使用Caerulin诱导的急性胰腺炎大鼠模型,我们发现JAK2 / STAT3信号在胰腺中被激活并且在AP中全身性炎症增加。抑制剂AG490对JAK2的药理学抑制强烈保护免受组织损伤,减弱JAK2 / STAT3信号传导和炎症反应。与喂食饲料的动物相比,喂食高脂肪饮食的动物胰腺组织中的局部胰腺组织损伤和磷酸化JAK2增强。有趣的是,JAK2抑制剂AG490显着抑制喂食高脂肪或食物饲料的动物的胰腺坏死和全身性炎症,但不影响STAT3信号传导。 结论:这些结果表明,JAK2活化通过调节坏死和全身炎症,在动物的周围和高脂饮食中的Caerulin诱导的AP的发病中起重要作用。因此,我们的研究结果不仅阐明了AP中新的信号转导机制,而且也表明JAK2可能构成高脂血症增强的caerulin诱导的AP的治疗目标。
关键词: 胰腺炎,JAK2 / STAT3信号传导,坏死,炎症,高脂血症,caerulin。
Current Molecular Medicine
Title:Inhibition of JAK2 Signaling Alleviates Hyperlipidemia-Intensified Caerulin-Induced Acute Pancreatitis In Vivo
Volume: 17 Issue: 5
关键词: 胰腺炎,JAK2 / STAT3信号传导,坏死,炎症,高脂血症,caerulin。
摘要: Rationale: Studies have implied the positive association of JAK2/STAT3 signaling with the onset and severity of acute pancreatitis (AP). However, definitive functional study of JAK2/STAT3 signaling in the pathogenesis of acute pancreatitis in vivo is missing and its potential as a therapeutic target and the underlying mechanisms remain to be determined.
Objectives: The aim of this study was to explore the role of JAK2/STAT3 signaling in the pathogenesis of hyperlipidemia-intensified caerulin-induced AP and its potential as a therapeutic target.
Methods and Results: Using the caerulin-induced acute pancreatitis rat model, we showed that JAK2/STAT3 signaling was activated in pancreas and systemic inflammation was increased during AP. Pharmacological suppression of JAK2 by its inhibitor AG490 robustly protected against tissue damage, attenuated JAK2/STAT3 signaling and inflammatory responses. Local pancreatic tissue damage and phosphor- JAK2 in the pancreatic tissue were enhanced in animals fed with high fat diet compared to chow-diet fed animals. Interestingly, JAK2 inhibitor AG490 significantly inhibited pancreas necrosis and systemic inflammation in animals fed with high fat or chow-diet, but did not affect STAT3 signaling.
Conclusion: These results establish that JAK2 activation plays a significant role in the pathogenesis of caerulin-induced AP in animals on both chow and high-fat diets by regulating necrosis and systemic inflammation. Thus, our results not only clarify novel signaling mechanisms in AP but also suggest that JAK2 might constitute a target in the management of hyperlipidemia-intensified caerulin-induced AP.
Export Options
About this article
Cite this article as:
Inhibition of JAK2 Signaling Alleviates Hyperlipidemia-Intensified Caerulin-Induced Acute Pancreatitis In Vivo, Current Molecular Medicine 2017; 17 (5) . https://dx.doi.org/10.2174/1566524018666171205123723
DOI https://dx.doi.org/10.2174/1566524018666171205123723 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Polydeoxyribonucleotide (PDRN): A Safe Approach to Induce Therapeutic Angiogenesis in Peripheral Artery Occlusive Disease and in Diabetic Foot Ulcers
Cardiovascular & Hematological Agents in Medicinal Chemistry Immunotherapy for Food Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Immune-Inflammation in Atherosclerosis: A New Twist in an Old Tale
Endocrine, Metabolic & Immune Disorders - Drug Targets Clinical Development of MET Targeted Therapy For Human Cancer
Current Cancer Therapy Reviews Metabolic Effects of Bile Acids in the Gut in Health and Disease
Current Medicinal Chemistry Systematic Investigation of the Effects of Long-Term Administration of a High-Fat Diet on Drug Transporters in the Mouse Liver, Kidney and Intestine
Current Drug Metabolism Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential
Current Medicinal Chemistry Synthesis of Some New Flurbiprofen Analogues as Anti-inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Patents and Recent Innovations in Topical Membrane Therapy of Refractory Rhinosinusitis
Recent Patents on Inflammation & Allergy Drug Discovery HHT in Childhood: Screening for Special Patients
Current Pharmaceutical Design Controversies in Glaucoma: Current Medical Treatment and Drug Development
Current Pharmaceutical Design A Potential Therapeutic Target RNA-binding Protein, Arid5a for the Treatment of Inflammatory Disease Associated with Aberrant Cytokine Expression
Current Pharmaceutical Design Dual Carbonic Anhydrase - Cyclooxygenase-2 Inhibitors
Current Topics in Medicinal Chemistry Combination of Phytochemicals as Adjuvants for Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Biomarkers Associated with Vulnerable Atheromatous Plaque
Current Medicinal Chemistry The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations
Current Medicinal Chemistry Hair Regeneration Therapy: Application of Adipose-Derived Stem Cells
Current Stem Cell Research & Therapy Host Stress and Virulence Expression in Intestinal Pathogens: Development of Therapeutic Strategies Using Mice and C. elegans
Current Pharmaceutical Design Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy Human Embryonic and Induced Pluripotent Stem Cell Based Toxicity Testing Models: Future Applications in New Drug Discovery
Current Medicinal Chemistry